|
|
|
Volumn 107, Issue 5, 2003, Pages
|
|
Transforming growth factor-beta function blocking already effective as therapeutic strategy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
MONOCLONAL ANTIBODY;
TGFB2 PROTEIN, HUMAN;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
ANIMAL;
CARDIOMYOPATHY;
DIASTOLE;
DRUG ANTAGONISM;
FIBROSIS;
GLAUCOMA;
HUMAN;
NOTE;
PHASE 3 CLINICAL TRIAL;
RAT;
SCAR;
TREATMENT OUTCOME;
ANIMALS;
ANTIBODIES, MONOCLONAL;
CARDIOMYOPATHIES;
CICATRIX;
CLINICAL TRIALS, PHASE III;
DIASTOLE;
FIBROSIS;
GLAUCOMA;
HUMANS;
OLIGONUCLEOTIDES, ANTISENSE;
RATS;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
TREATMENT OUTCOME;
|
|
EID: 0037432115
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
